大量研究表明,对糖尿病病人劳动力及生命威胁最大的是大血管及微血管并发症。这与糖尿病病人经常伴有的脂代谢紊乱有关。同时有人认为长期口服西药降糖药,包括磺酰脲类(Salfouylurea)或双胍类(biguanide)能增加心血管病死亡率。因此,寻找具有降血脂作用的口服降糖药具有十分重要的意义。 A large number of studies have shown that the biggest threat to the labor and life of diabetic patients is the major vascular and microvascular complications. This is related to the disorder of lipid metabolism that is often associated with diabetic patients. At the same time, it has been suggested that long-term oral oral antidiabetics, including sulfonylureas (Salfouylurea) or biguanide, can increase cardiovascular mortality. Therefore, it is of great significance to look for oral hypoglycemic agents with hypolipidemic effects.